Phenolic A ring requirement for the neuroprotective effects of steroids.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 9459189)

Published in J Steroid Biochem Mol Biol on February 18, 1998

Authors

P S Green1, K Gordon, J W Simpkins

Author Affiliations

1: Center for the Neurobiology of Aging and the Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville 32610, USA.

Articles citing this

Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A (2001) 2.40

The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A (1999) 1.56

Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta (2009) 1.25

Estrogen actions on mitochondria--physiological and pathological implications. Mol Cell Endocrinol (2008) 1.11

Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Pharmacol Ther (2007) 1.09

Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci (2006) 1.05

Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative. Steroids (2007) 1.02

Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens. Front Neuroendocrinol (2009) 0.96

Mitochondrial nuclear receptors and transcription factors: who's minding the cell? J Neurosci Res (2008) 0.95

Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens. Cell Mol Neurobiol (1999) 0.93

HIV neurotoxicity: potential therapeutic interventions. J Biomed Biotechnol (2006) 0.90

The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther Adv Neurol Disord (2009) 0.87

The assessment of non-feminizing estrogens for use in neuroprotection. Brain Res (2010) 0.87

Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin Neurosci (2002) 0.86

The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start? Adv Drug Deliv Rev (2009) 0.85

Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology (2008) 0.84

Complete recovery after antepartum massive intracerebral hemorrhage in an atypical case of sudden eclampsia. Surg Neurol Int (2012) 0.84

Protective role of endogenous ovarian hormones against learning and memory impairments and brain tissues oxidative damage induced by lipopolysaccharide. Iran Red Crescent Med J (2014) 0.83

From the 90׳s to now: A brief historical perspective on more than two decades of estrogen neuroprotection. Brain Res (2015) 0.83

Non-feminizing estrogens: a novel neuroprotective therapy. Mol Cell Endocrinol (2014) 0.81

Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons. Invest Ophthalmol Vis Sci (2012) 0.81

The effects of soy extract on spatial learning and memory damage induced by global ischemia in ovariectomised rats. Malays J Med Sci (2014) 0.80

Comparison of estrogen-derived ortho-quinone and para-quinol concerning induction of oxidative stress. J Steroid Biochem Mol Biol (2007) 0.80

Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy. Horm Behav (2012) 0.80

HRT and its effect on normal ageing of the brain and dementia. Br J Clin Pharmacol (2001) 0.79

Neuroprotective actions of the synthetic estrogen 17alpha-ethynylestradiol in the hippocampus. Cell Mol Neurobiol (2010) 0.76

A facile total synthesis of ent-17beta-estradiol and structurally related analogues. Steroids (2006) 0.76

Reprint of: From the 90׳s to now: A brief historical perspective on more than two decades of estrogen neuroprotection. Brain Res (2016) 0.75

A novel mechanism of non-feminizing estrogens in neuroprotection. Exp Gerontol (2016) 0.75

Articles by these authors

(truncated to the top 100)

Fractionation and identification of spinach chloroplast transfer RNAs and mapping of their genes on the restriction map of chloroplast DNA. Gene (1979) 2.82

Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58

Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trials. J Child Neurol (1996) 2.14

Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study. Neurology (1992) 2.08

Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02

Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication. J Pediatr (1993) 1.93

Building skills of recovering women drug users to reduce heterosexual AIDS transmission. Public Health Rep (1991) 1.86

Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci (2000) 1.75

Extensive synteny conservation of holocentric chromosomes in Lepidoptera despite high rates of local genome rearrangements. Proc Natl Acad Sci U S A (2010) 1.74

Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia (1996) 1.73

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis (2009) 1.71

Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod (2011) 1.69

Which child will have a febrile seizure? Am J Dis Child (1993) 1.68

Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64

The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology (1995) 1.61

Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (1991) 1.61

Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60

If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug? J Pediatr (1997) 1.57

Psoriasis treatment: current and emerging directed therapies. Ann Rheum Dis (2005) 1.56

Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey (Macaca fascicularis) model of endometriosis. Fertil Steril (1996) 1.56

Pathology in the Hundred Acre Wood: a neurodevelopmental perspective on A.A. Milne. CMAJ (2000) 1.52

DISCUSSION ON THE DIFFERENTIAL DIAGNOSIS OF NON-TUBERCULOUS COXITIS IN CHILDREN AND ADOLESCENTS. Proc R Soc Med (1925) 1.51

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int (2001) 1.50

A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc Natl Acad Sci U S A (1988) 1.49

Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol (2001) 1.49

Terminology for GnRH antagonists. Fertil Steril (1994) 1.47

The potential use of cyclodextrins in parenteral formulations. J Parenter Sci Technol (1989) 1.43

Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol (1995) 1.41

A functional DNA methylation system in the pea aphid, Acyrthosiphon pisum. Insect Mol Biol (2010) 1.41

Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int (1995) 1.41

Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int (1991) 1.39

Prevention of recurrent febrile seizures. J Pediatr (1995) 1.39

Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke (2000) 1.38

Positive and negative control of translation by the leader sequence of cauliflower mosaic virus pregenomic 35S RNA. EMBO J (1990) 1.37

A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci (1997) 1.36

Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats. Brain Res (1998) 1.32

Differential inhibition of downstream gene expression by the cauliflower mosaic virus 35S RNA leader. Virus Genes (1989) 1.30

Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res (1994) 1.30

Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression. Biotechnology (N Y) (1991) 1.27

Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest (1992) 1.26

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26

Effects of gender and estradiol treatment on focal brain ischemia. Brain Res (1998) 1.23

Biologic factors as predictors of social outcome of epilepsy in intellectually normal children: a population-based study. J Pediatr (1993) 1.20

17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci (1997) 1.20

What types of epilepsy are preceded by febrile seizures? A population-based study of children. Dev Med Child Neurol (1994) 1.20

The leading sequence of caulimovirus large RNA can be folded into a large stem-loop structure. Nucleic Acids Res (1988) 1.18

The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology (2001) 1.16

Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem (2001) 1.16

Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest (1992) 1.15

CANDEES. The Canadian Dry Eye Epidemiology Study. Adv Exp Med Biol (1998) 1.14

Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res (2000) 1.13

Cauliflower mosaic virus produces an aspartic proteinase to cleave its polyproteins. EMBO J (1989) 1.10

Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am J Pathol (1997) 1.10

The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet (2013) 1.10

Presence of a transfer RNA gene in the spacer sequence between the 16 S and 23 S rRNA genes of spinach chloroplast DNA. FEBS Lett (1979) 1.08

Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med (2000) 1.07

Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int (1995) 1.07

Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol (1993) 1.06

Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less. Neurology (1996) 1.04

Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int (1996) 1.04

Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol (1994) 1.02

Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res (1991) 1.02

Patient and provider-reported symptoms in the post-cART era. AIDS Behav (2011) 1.01

Can good bed management solve the overcrowding in accident and emergency departments? Emerg Med J (2003) 1.00

The determination of an immunologically active dose of interferon-gamma in patients with melanoma. J Clin Oncol (1988) 1.00

The mammary tumor response in triazine-treated female rats: a threshold-mediated interaction with strain and species-specific reproductive senescence. Steroids (1999) 0.99

The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J Clin Invest (1996) 0.99

Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci (1994) 0.98

The molecular composition of neuronal microfilaments is spatially and temporally regulated. J Neurosci (1996) 0.96

Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience (1998) 0.96

Reduced neonatal liver iron concentrations after uteroplacental insufficiency. J Pediatr (1995) 0.96

The plasma membrane-actin linking protein, ezrin, is a glomerular epithelial cell marker in glomerulogenesis, in the adult kidney and in glomerular injury. Kidney Int (1998) 0.95

Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett (1996) 0.95

Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase. J Am Soc Nephrol (1992) 0.95

Effects of estradiol and progesterone on the sensitivity to pain and on morphine-induced antinociception in female rats. Horm Behav (1991) 0.94

The dental management of adult patients with haemophilia and other congenital bleeding disorders. Haemophilia (2003) 0.94

Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res Bull (1995) 0.94

Transfer RNA genes associated with the 16S and 23S rRNA genes of Euglena chloroplast DNA. Biochem Biophys Res Commun (1980) 0.93

A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol Pharmacol (1998) 0.93

Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens. Cell Mol Neurobiol (1999) 0.93

17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol (1997) 0.93

Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. Kidney Int (1992) 0.93

Production of human tissue plasminogen activator in transgenic mouse milk. 1987. Biotechnology (1992) 0.93

Definition of the anterior choroidal artery territory in rats using intraluminal occluding technique. J Neurol Sci (2000) 0.93

Cloning of the goat beta-casein-encoding gene and expression in transgenic mice. Gene (1992) 0.92

The multi-state Kalman Filter in medical monitoring. Comput Methods Programs Biomed (1986) 0.92

Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: purification and characterization of the recombinant enzyme. Biotechnology (N Y) (1991) 0.92

Tissue distribution of cocaine in the pregnant rat. Life Sci (1989) 0.92

Survey of administration of medicines to pupils in primary schools within the London area. Arch Dis Child (2004) 0.92

Weighing up the weighted case mix tool (WCMT): a psychometric investigation using confirmatory factor analysis. Community Dent Health (2014) 0.91

Mathematical and statistical aids to evaluate data from renal patients. Kidney Int (1983) 0.91

Estrogen attenuates over-expression of beta-amyloid precursor protein messager RNA in an animal model of focal ischemia. Brain Res (1998) 0.91

Synthesis and biological evaluation of 17beta-alkoxyestra-1,3, 5(10)-trienes as potential neuroprotectants against oxidative stress. J Med Chem (2001) 0.91

Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann N Y Acad Sci (2000) 0.91

Discontinuation of anticonvulsant therapy in children free of seizures for 1 year: a prospective study. Neurology (1996) 0.91

Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model. Stroke (2001) 0.91

Experimental model of small deep infarcts involving the hypothalamus in rats: changes in body temperature and postural reflex. Stroke (1999) 0.90

Age-related decline in adrenergic responsiveness of the kidney, heart and aorta of male rats. Neurobiol Aging (1983) 0.90

17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage. J Cereb Blood Flow Metab (2001) 0.89

Resumption with clonidine of pulsatile LH release following acute norepinephrine depletion in ovariectomized rats. Neuroendocrinology (1982) 0.88